Related Experiment Video
Updated: Jun 25, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
[Vaccination against bluetongue: safety and immune response in the field]
1Institut für Viruskrankheiten und Immunprophylaxe (IVI), Mittelhäusern. lukas.bruckner@ivi.admin.ch
Abstract:
Bluetongue, caused by the bluetongue virus serotype 8 has rapidly spread through Europe since 2006. The first cases in Switzerland were detected in October 2007. The European Union and Switzerland launched a vaccination campaign in June 2008. This study aims to demonstrate the safety and the immune response of the three vaccines used in Switzerland under practical conditions in the field. The trial was carried out in cattle, sheep and goats. Based on the results of this study recommendations for the 2009 campaign are presented.
More Related Videos
08:13Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
Published on: January 20, 2019
15:57Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
Related Concept Videos
Vaccinations
Humoral Immune Responses
Vaccines
Smallpox
Vaccine Production
Cross-reactivity